On November 09, 2015 13:42 (IST)
The two drugmakers did not give any deadline for the issues to be resolved. Kotak analysts, however, estimate Sun Pharma's Halol site - a site it had owned before the Ranbaxy deal - could be cleared by the second half of 2016.
On November 09, 2015 12:38 (IST)
Consolidated net sales of the company declined to Rs 6,803.31 crore for the quarter under consideration as against Rs 7,979.31 crore for the same period a year ago.
On November 03, 2015 11:27 (IST)
Drug major Sun Pharmaceutical Industries on Tuesday said it has completed acquisition of US-based eye care firm InSite Vision.
On November 02, 2015 12:16 (IST)
Sun Pharma shares fell over 3 per cent on Monday after India's biggest pharma company said it expects revenues and net profit to be adversely hit in the short term due to supply constraints at its Halol facility in Gujarat and high expenses arising out of Ranbaxy integration as well as remedial actions.
On October 29, 2015 01:07 (IST)
Sun Pharmaceutical Industries on Wednesday said its arm Thea Acquisition Corp plans to exercise a 'top-up' option to purchase shares directly from eyecare firm InSite Vision to hold a 90 per cent stake in the US-based company to complete a merger, after failing to get the required number of shares through a tender offer.
On October 06, 2015 16:29 (IST)
Shares of Sun Pharma gained as much as 2 per cent on Tuesday after Ranbaxy Pharmaceuticals, a unit of India's biggest pharma company, settled a patent litigation with Actavis over the generic version of Absorica, which is used to treat acne.
On September 29, 2015 21:05 (IST)
The company "has commenced a tender offer through its indirect wholly owned subsidiary, Thea Acquisition Corporation, for all of the outstanding shares of common stock of InSite Vision Incorporated for $0.35 per share in cash, without interest and less any required withholding taxes," Sun Pharma said in a statement.
On September 22, 2015 16:08 (IST)
Sparc plans to use proceeds from the rights issue for R&D and clinical trials. The Board of Directors of Sparc at its meeting held on May 12, 2015, had approved the rights issue.
On September 21, 2015 15:40 (IST)
Shares of Strides Arcolab surged nearly 4 per cent to Rs 1,191 at its day's high after the Bangalore-based pharma company reached a deal with Sun Pharmaceutical Industries Ltd to buy two marketing divisions of erstwhile Ranbaxy Laboratories.
On September 16, 2015 15:58 (IST)
The transaction is subject to InSite Vision's stockholders tendering a majority of its outstanding shares under the Sun Pharma offer.
On September 14, 2015 16:07 (IST)
Sun Pharmaceutical Industries shares jumped as much as 1.6 per cent to hit intraday high of Rs 859.05 on the back of slew of news developments.
On August 31, 2015 15:52 (IST)
Aurobindo Pharma shares jumped as much as 3.3 per cent to hit intraday high of Rs 779.70 after the company got approval from the US Food and Drug Administration (USFDA) to manufacture and market generic version of Eli Lilly's Evista tablets used for treatment of osteoporosis in post-menopausal women.
On August 14, 2015 12:16 (IST)
Stocks that will become a part of the MSCI India index, or those whose weightage is slated to go up, are likely to witness buying from passive funds which track the MSCI India index. Stocks which will be excluded from the index are likely to witness selling from passive funds.
On August 12, 2015 15:58 (IST)
Sun Pharma's revenue growth was driven by the Indian formulation business, which posted an annual growth of 11 per cent to Rs 1,784 crore and emerging markets business, which grew 10 per cent year-on-year to Rs 845 crore.
On July 21, 2015 19:26 (IST)
International brokerage house Jefferies said it is positive about Sun Pharmaceutical Industries' strong key fundamentals, though its stock plunged 15 per cent on Tuesday, a day after the company warned of a deeper cut in bottom line and topline this year due to its ongoing integration with Ranbaxy.
On July 21, 2015 14:51 (IST)
Indian shares were little changed in choppy trading on Tuesday as investors remained focussed on corporate earnings, while Infosys issued an upbeat outlook and Sun Pharmaceutical Industries warned on 2016 sales.
On July 21, 2015 23:10 (IST)
Analysts estimate a roughly 8-10 per cent hit to profit for the year as Sun Pharma struggles to fix manufacturing problems at one of its own key plants and those of Ranbaxy Laboratories, the troubled rival it bought last year.
On July 21, 2015 10:25 (IST)
Shares of Sun Pharmaceutical Industries slumped as much as 16 per cent to Rs 799 on Tuesday after India's largest drugmaker issued an earnings warning.
On June 01, 2015 16:39 (IST)
Sun Pharmaceutical shares fell over 8 per cent on Monday following the drugmaker's disappointing quarterly results in the March quarter. Sun Pharma, India's largest drugmaker by sales, had posted its Q4 numbers post market hours on Friday.
On May 15, 2015 11:37 (IST)
Sun Pharma is India's largest drugmaker.